Medical Properties Trust, Inc. (NYSE:MPW) Receives Consensus Rating of “Hold” from Analysts

Shares of Medical Properties Trust, Inc. (NYSE:MPW) have received an average rating of “Hold” from the ten analysts that are presently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, eight have issued a hold recommendation and one has issued a buy recommendation on the company. The average 12 month price target among brokers that have covered the stock in the last year is $5.38.

A number of brokerages have issued reports on MPW. BNP Paribas downgraded Medical Properties Trust from an “outperform” rating to a “neutral” rating and cut their target price for the stock from $6.00 to $4.00 in a research note on Tuesday, July 2nd. Colliers Securities raised Medical Properties Trust from a “neutral” rating to a “buy” rating and set a $6.50 price objective for the company in a research note on Friday, September 13th. Truist Financial increased their target price on shares of Medical Properties Trust from $5.00 to $6.00 and gave the stock a “hold” rating in a report on Friday, September 13th. Finally, Wolfe Research upgraded Medical Properties Trust to a “hold” rating in a research note on Monday, September 23rd.

Insider Buying and Selling at Medical Properties Trust

In other news, Director C Reynolds Thompson III sold 20,530 shares of the business’s stock in a transaction that occurred on Tuesday, August 27th. The stock was sold at an average price of $4.38, for a total value of $89,921.40. Following the transaction, the director now owns 54,637 shares of the company’s stock, valued at approximately $239,310.06. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In related news, Director Elizabeth N. Pitman bought 8,087 shares of the stock in a transaction on Wednesday, September 18th. The shares were bought at an average cost of $6.01 per share, for a total transaction of $48,602.87. Following the completion of the transaction, the director now owns 76,740 shares of the company’s stock, valued at $461,207.40. This represents a 0.00 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director C Reynolds Thompson III sold 20,530 shares of the company’s stock in a transaction that occurred on Tuesday, August 27th. The stock was sold at an average price of $4.38, for a total value of $89,921.40. Following the completion of the sale, the director now owns 54,637 shares in the company, valued at approximately $239,310.06. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 63,335 shares of company stock worth $318,825. 1.53% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. raised its stake in Medical Properties Trust by 8.2% in the 1st quarter. Vanguard Group Inc. now owns 93,058,174 shares of the real estate investment trust’s stock valued at $437,373,000 after purchasing an additional 7,084,981 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in shares of Medical Properties Trust by 4.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 8,622,683 shares of the real estate investment trust’s stock valued at $37,168,000 after purchasing an additional 328,184 shares in the last quarter. Bank of New York Mellon Corp grew its stake in Medical Properties Trust by 22.6% during the second quarter. Bank of New York Mellon Corp now owns 6,908,362 shares of the real estate investment trust’s stock worth $29,775,000 after buying an additional 1,274,481 shares during the period. Wilsey Asset Management Inc. increased its holdings in Medical Properties Trust by 27.2% in the 2nd quarter. Wilsey Asset Management Inc. now owns 4,376,180 shares of the real estate investment trust’s stock valued at $18,861,000 after purchasing an additional 936,631 shares in the last quarter. Finally, Goldentree Asset Management LP acquired a new stake in shares of Medical Properties Trust in the first quarter valued at about $15,966,000. Hedge funds and other institutional investors own 71.79% of the company’s stock.

Medical Properties Trust Stock Performance

Shares of NYSE MPW opened at $4.74 on Tuesday. Medical Properties Trust has a 1 year low of $2.92 and a 1 year high of $6.55. The company has a debt-to-equity ratio of 1.51, a quick ratio of 2.93 and a current ratio of 2.93. The company has a market capitalization of $2.84 billion, a PE ratio of -2.14, a price-to-earnings-growth ratio of 0.76 and a beta of 1.29. The company’s fifty day moving average price is $5.15 and its 200 day moving average price is $4.90.

Medical Properties Trust (NYSE:MPW) last released its earnings results on Thursday, August 8th. The real estate investment trust reported ($0.54) EPS for the quarter, missing analysts’ consensus estimates of $0.21 by ($0.75). The firm had revenue of $266.60 million for the quarter, compared to analyst estimates of $259.53 million. The firm’s quarterly revenue was down 21.0% on a year-over-year basis. During the same period in the prior year, the company earned $0.48 earnings per share. On average, research analysts predict that Medical Properties Trust will post 0.85 earnings per share for the current year.

Medical Properties Trust Cuts Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, October 10th. Stockholders of record on Monday, September 9th were given a dividend of $0.08 per share. The ex-dividend date was Monday, September 9th. This represents a $0.32 dividend on an annualized basis and a dividend yield of 6.75%. Medical Properties Trust’s dividend payout ratio (DPR) is presently -14.41%.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.